Takeshi Koyama
Vorstandsvorsitzender bei Fujirebio Diagnostics, Inc.
Profil
Takeshi Koyama is currently the President, Chief Executive Officer & Director at Fujirebio Diagnostics, Inc. since 2013.
He is also currently the Chairman at Fujirebio Europe NV since 2011.
Previously, he held positions as the President & Representative Director at Fujirebio, Inc., Director at Inform Diagnostics, Inc., Director & Executive Officer at H.U.
Group Holdings, Inc. from 2010 to 2012, Director at Fujirebio America, Inc., and Director at Fujirebio Europe BV.
Aktive Positionen von Takeshi Koyama
Unternehmen | Position | Beginn |
---|---|---|
Fujirebio Diagnostics, Inc.
Fujirebio Diagnostics, Inc. Medical SpecialtiesHealth Technology Fujirebio Diagnostics, Inc. develops, manufactures and commercializes in-vitro diagnostic products. Its products include oncology RIA and EIA kits, veterinary products and research kits. The company was founded in 1965 and is headquartered in Malvern, PA | Vorstandsvorsitzender | 01.04.2013 |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Vorsitzender | 01.11.2011 |
Ehemalige bekannte Positionen von Takeshi Koyama
Unternehmen | Position | Ende |
---|---|---|
Inform Diagnostics, Inc.
Inform Diagnostics, Inc. Hospital/Nursing ManagementHealth Services Inform Diagnostics, Inc. provides pathology diagnostic services. It offers subspecialty anatomic pathology in the fields of breast health, dermatology, gastroenterology, hematology, and urology. The company was founded by David D. Halbert and Harold Roe in 1996 and is headquartered in Irving, TX. | Direktor/Vorstandsmitglied | - |
Fujirebio Europe BV | Direktor/Vorstandsmitglied | - |
Fujirebio, Inc.
Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | Präsident | - |
Fujirebio America, Inc. | Direktor/Vorstandsmitglied | - |
H.U. GROUP HOLDINGS, INC. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
H.U. GROUP HOLDINGS, INC. | Health Services |
Private Unternehmen | 6 |
---|---|
Fujirebio, Inc.
Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | Health Technology |
Fujirebio America, Inc. | |
Fujirebio Europe BV | |
Fujirebio Diagnostics, Inc.
Fujirebio Diagnostics, Inc. Medical SpecialtiesHealth Technology Fujirebio Diagnostics, Inc. develops, manufactures and commercializes in-vitro diagnostic products. Its products include oncology RIA and EIA kits, veterinary products and research kits. The company was founded in 1965 and is headquartered in Malvern, PA | Health Technology |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
Inform Diagnostics, Inc.
Inform Diagnostics, Inc. Hospital/Nursing ManagementHealth Services Inform Diagnostics, Inc. provides pathology diagnostic services. It offers subspecialty anatomic pathology in the fields of breast health, dermatology, gastroenterology, hematology, and urology. The company was founded by David D. Halbert and Harold Roe in 1996 and is headquartered in Irving, TX. | Health Services |